Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Diversified investors have not been rewarded so far in 2024 as the tech-heavy SPX has outperformed value strategies and the total return of defensive sectors. But Altria presents solid fundamentals with high free cash flow, steady EPS growth, and an attractive dividend yield. Altria's technical view has improved with resistance at $47-$49, support at 200-day moving average following a break of a multi-year downtrend.

Altria: A Near-9% Yield With Buybacks, Bulls Break The Downtrend

Smoking causes cardiovascular diseases, even with minimal cigarette consumption. Nonetheless, its production has played a major role in America's history. Since 2005 Altria's stock performance has outperformed the S&P 500 but has stagnated since 2017. Altria's strategic shift towards e-vapor products and strong dividends make it a compelling option for income-focused investors.

Altria With 9% Dividend Yield - Because America Was Built On Tobacco

AT&T

A pair of companies that have been paying dividends for decades offer yields above 6% at recent prices. AT&T's telephone business is down, but its broadband internet services keep offsetting the losses.

Better High-Yield Dividend Stock to Buy Now: AT&T vs. Altria Group

AllianceBernstein Hld

Bristol-Myers

Kinder Morgan

MPLX

Whirlpool

The artificial intelligence rally over the past year and a half, led by the so-called Magnificent 7 stocks, has been remarkable if you owned those stocks.

Goldman Sachs Has 6 High-Yield Dividend Stocks to Buy in June

British American Tobacco

The decline in cigarette smoking has forced tobacco companies to focus on different product categories. Altria has steadily boosted the prices of cigarettes to offset its falling sales volume.

Want Safe Dividend Income in 2024 and Beyond? Invest in These 2 Ultra-High-Yield Stocks.

Pfizer

SL Green Realty

The markets had a strong week, with the S&P 500 gaining 0.97% and the Dow Jones Industrial Average gaining 1.6%. Yields on the 10-year Treasury shot up to 4.9% ahead of the FOMC meeting. The Dividend Harvesting Portfolio traded sideways but continues to generate consistent dividend income and exceed invested capital.

Dividend Harvesting Portfolio Week 171: $17,100 Allocated, $1,524.12 In Projected Dividends

Agree Realty

Johnson & Johnson

Realty Income Corp

Schwab US Dividend Equity ETF

Vici Properties

Exxon Mobil

Building a solid retirement portfolio to carry you through your golden years requires just a few key ingredients like income reliability, dividend growth and exceptional yield. That's because retirement is not the time to take fliers on penny stocks.

Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June

Coca-Cola

Ex-Dividend Reminder: Coca-Cola, Altria Group And Meta Platforms

Dover

Parker-Hannifin

Dover and Parker-Hannifin both boast dividend-hiking streaks that stretch more than five decades. Coca-Cola generates consistent free cash flows that help power its reliable dividend growth.

4 Dividend Stocks to Double Up on Right Now

Innovative Industrial Properties

Verizon

High-yield dividend stocks exemplify stability and growth potential for astute investors in today's investing environment. These firms show strong financial performance and strategic insight in addition to providing appealing dividend yields.

3 High-Yield Dividend Stocks to Buy for Huge Returns

Altria spent years unwinding a high valuation that imploded with its Juul investment. The dividend remains the crown jewel.

Is It Too Late to Buy Altria Group Stock?

Deere & Company

Genuine Parts

Selecting dividend stocks to buy involves more than just pursuing high yields. Many companies with limited growth prospects resort to distributing excess cash to shareholders to keep the wolves (activist investors and angry stakeholders) at bay rather than face scrutiny for stagnant operational models.

3 Dividend Stocks to Own for Reliable Income Streams

A more conservative goal of $100 monthly dividend income would require owning 306 shares of Altria Group.

How To Earn $500 A Month From Altria Group Stock

The jury is still out on the safety of the chemical additives that go into the popular devices.

Juul E-Cigarette Ban Reversed Pending FDA Review

Ares Capital

Imperial Brands PLC

Blue Owl Capital Corp

Philip Morris

Sixth Street Specialty Lending

Sixth Street Specialty Lending offers a solid 8.7% yield and has consistently outperformed its peers through strategic first lien loans and robust portfolio management. Imperial Brands has undergone significant transformation and achieved solid progress in next-generation products, offering an appealing dividend yield of 7.3%. Both TSLX and IMBBY provide investors with reliable cash flow and potential for long-term value creation, making them appealing additions to a dividend-focused portfolio.

Buy These Smart 7-9% Yields Before The Market Wakes Up To Income

Hercules Capital

Hercules Capital is a business development company that provides venture capital to fledgling life science businesses and technology start-ups. Hercules Capital offers a standard distribution plus a supplemental dividend at the moment.

2 Reliable Dividend Stocks With Yields Above 8% That You Can Buy With $100 Now and Hold Forever

Walgreens

Walgreens Boots Alliance cut its dividend earlier this year, but even with the new payout, its yield remains high. Altria faces a challenging road ahead as tobacco use declines, but the company's dividend still looks safe right now.

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

The US Food and Drug Administration (FDA) is rescinding an order that blocked the sale of Juul's products, including its e-cigarettes. The FDA in June 2022 banned all of Juul's products in the US, including the Juul device and four types of flavored Juul pods, on the basis that there was not sufficient evidence the marketing of the products would be appropriate for the protection of public health.

Juul e-cigarettes back under FDA review after marketing ban lifted

The U.S. Food and Drug Administration said Thursday that it has rescinded its 2022 orders blocking the marketing of Juul Labs Inc.'s e-cigarette products in the U.S.

Juul e-cigarettes' FDA ban lifted

The Food and Drug Administration rescinded its ban on Juul Lab's e-cigarette products Thursday—placing them back under scientific review—nearly two years after ordering a ban that was halted pending the company's appeal.

FDA Rescinds Ban On Juul E-Cigarettes

The U.S. Food and Drug Administration (FDA) said on Thursday it was rescinding a June 2022 order that briefly blocked sale of Juul's products, including its device for e-cigarettes.

US FDA rescinds market denial order for Juul products

Altria NYSE: MO is among the leading sin stocks but is still a good dividend play today. Up more than 17.5% in the last few weeks, the purveyor of tobacco products is on track to reclaim the high end of a long-term trading range and possibly set new highs.

Why Altria Stock is Still a Good Dividend Play

Chevron

Sell in May and go away? Maybe not this year, but be careful. Altria Group Inc. (NYSE MO) still owns 8% of Anheuser-Busch InBev S.A. (NYSE: BUD) after selling millions of shares.

My 3 Top Stocks to Buy in June

Enterprise Products Partners

Eversource Energy

National Retail Properties

The key for investors with this group is that they don't have to be in the S&P 500 and can be any market cap size.

The 7 Highest Yielding Dividend Champions Are Passive Income Winners

While traders are naturally attracted to high-growth stocks that deliver impressive returns, savvy investors prefer dividend stocks. Growth stocks can be highly rewarding if picked correctly, but they also carry greater risk.

News for Altria Stock (MO)